Allen Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Allen Wang has a total of 403 co-authors. Here are the top co-authors by number of shared publications:
- Bing Ren
New York Genome Center; New York, NY, USA
47 shared publications - Angela H. Ting
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
39 shared publications - Angela Halstead
Division of Gastroenterology Department of Medicine Washington University in St. Louis School of Medicine St. Louis Missouri USA
39 shared publications - Byron H. Lee
Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
39 shared publications - Daniel J. Lindner
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, USA
39 shared publications - Daniel Kim
Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
39 shared publications
Latest Publications
- Open Access
p53 supports healthy aging
P53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.
Open Accessp53 supports healthy aging
P53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.
- Open Access
Age-associated repression of HNF4α is a driver and potential therapeutic target in liver metabolic dysfunction
Aging is a major risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the mechanisms by which aging disrupts hepatocyte transcriptional networks to drive metabolic dysfunction remain poorly understood. Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte identity and metabolic homeostasis, but its role in liver aging has not been defined. Here, we perform a comprehensive multi-omic profiling of young and aged mouse livers combined with targeted HNF4α functional studies to define how aging remodels HNF4α-dependent gene regulation and whether HNF4α can be a target to reverse age-associated liver dysfunction. Despite preserved HNF4α expression with age, aging was associated with reduced HNF4α chromatin occupancy and transcriptional activity, accompanied by epigenetic remodeling, including changes in histone acetylation, chromatin accessibility, and DNA methylation. Integration and comparison of HNF4α CUT&RUN with hepatocyte-specific Hnf4a deletion in young and aged livers identified high-confidence overlapping but distinct young- and old-specific HNF4α target gene networks. In young hepatocytes, HNF4α coordinates two complementary transcriptional programs: activation of genes governing hepatocyte identity, lipid metabolism, and metabolic function, while simultaneously inhibiting alternative developmental, proliferative, and inflammatory programs. Spatial transcriptomic analyses further revealed zone-specific specialization of HNF4α-dependent gene programs. Aging selectively disrupted these regulatory networks, resulting in compromised liver identity and metabolic gene programs, de-repression of inflammatory pathways and alternative cellular identity programs and disrupted hepatocyte zonation, consistent with age-dependent lipidomic and metabolic changes, hepatic fat accumulation, and immune infiltration. Hepatocyte-specific Hnf4a deletion in young mice recapitulated key features of liver aging, including impaired hepatocyte identity, metabolic dysfunction, steatosis, inflammatory activation and altered hepatic immune-cell composition, while deletion in aged mice further exacerbated steatosis, inflammation, and hepatic dysfunction. Conversely, hepatocyte-specific HNF4α restoration in aged mice significantly reduced hepatic steatosis and lipid accumulation, restored fatty acid metabolic programs, and partially reversed age-associated transcriptional changes. However, inflammatory and interferon-associated programs were not uniformly reversed, revealing differential responsiveness of metabolic and inflammatory pathways to HNF4α restoration. Together, these findings identify age-associated impairment of HNF4α activity as a functional contributor to liver aging, linking dysregulation of hepatocyte identity, metabolic homeostasis, and inflammatory control to age-associated hepatic dysfunction. Importantly, the selective reversibility of metabolic defects following HNF4α restoration establishes HNF4α as a promising strategy for preserving hepatocyte homeostasis and reversing age-associated hepatic metabolic dysfunction.
Open AccessAge-associated repression of HNF4α is a driver and potential therapeutic target in liver metabolic dysfunction
Aging is a major risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the mechanisms by which aging disrupts hepatocyte transcriptional networks to drive metabolic dysfunction remain poorly understood. Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of hepatocyte identity and metabolic homeostasis, but its role in liver aging has not been defined. Here, we perform a comprehensive multi-omic profiling of young and aged mouse livers combined with targeted HNF4α functional studies to define how aging remodels HNF4α-dependent gene regulation and whether HNF4α can be a target to reverse age-associated liver dysfunction. Despite preserved HNF4α expression with age, aging was associated with reduced HNF4α chromatin occupancy and transcriptional activity, accompanied by epigenetic remodeling, including changes in histone acetylation, chromatin accessibility, and DNA methylation. Integration and comparison of HNF4α CUT&RUN with hepatocyte-specific Hnf4a deletion in young and aged livers identified high-confidence overlapping but distinct young- and old-specific HNF4α target gene networks. In young hepatocytes, HNF4α coordinates two complementary transcriptional programs: activation of genes governing hepatocyte identity, lipid metabolism, and metabolic function, while simultaneously inhibiting alternative developmental, proliferative, and inflammatory programs. Spatial transcriptomic analyses further revealed zone-specific specialization of HNF4α-dependent gene programs. Aging selectively disrupted these regulatory networks, resulting in compromised liver identity and metabolic gene programs, de-repression of inflammatory pathways and alternative cellular identity programs and disrupted hepatocyte zonation, consistent with age-dependent lipidomic and metabolic changes, hepatic fat accumulation, and immune infiltration. Hepatocyte-specific Hnf4a deletion in young mice recapitulated key features of liver aging, including impaired hepatocyte identity, metabolic dysfunction, steatosis, inflammatory activation and altered hepatic immune-cell composition, while deletion in aged mice further exacerbated steatosis, inflammation, and hepatic dysfunction. Conversely, hepatocyte-specific HNF4α restoration in aged mice significantly reduced hepatic steatosis and lipid accumulation, restored fatty acid metabolic programs, and partially reversed age-associated transcriptional changes. However, inflammatory and interferon-associated programs were not uniformly reversed, revealing differential responsiveness of metabolic and inflammatory pathways to HNF4α restoration. Together, these findings identify age-associated impairment of HNF4α activity as a functional contributor to liver aging, linking dysregulation of hepatocyte identity, metabolic homeostasis, and inflammatory control to age-associated hepatic dysfunction. Importantly, the selective reversibility of metabolic defects following HNF4α restoration establishes HNF4α as a promising strategy for preserving hepatocyte homeostasis and reversing age-associated hepatic metabolic dysfunction.
- 20 August 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (9) , 1829-1848
Inhibiting cyclin D1–CDK6 suppresses senescence-associated inflammatory gene expression and age-related functional decline
Cellular senescence contributes to aging and age-related diseases by driving chronic inflammation through the senescence-associated secretory phenotype (SASP), including interferon-stimulated genes (ISGs). Here we confirm and extend previous observations that cyclin D1 (CCND1), a key cell cycle regulator, is paradoxically upregulated across models of nonproliferating senescent cells. We show that CCND1 and its kinase partner CDK6 drive SASP and ISG expression in senescent cells by promoting DNA damage accumulation. This leads to the formation of cytoplasmic chromatin fragments that activate pro-inflammatory cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling. In aged mouse livers, senescent hepatocytes show increased Ccnd1 expression. Hepatocyte-specific Ccnd1 knockout or treatment with the clinical grade CDK4/6 inhibitor palbociclib reduces DNA damage and ISGs in aged mouse liver. Further, palbociclib suppresses frailty and improves physical performance of aged mice. These findings demonstrate a role for CCND1/CDK6 in regulating DNA damage and inflammation in senescence and aging, highlighting it as a promising target for therapeutic repurposing.
- 20 August 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (9) , 1829-1848
Inhibiting cyclin D1–CDK6 suppresses senescence-associated inflammatory gene expression and age-related functional decline
Cellular senescence contributes to aging and age-related diseases by driving chronic inflammation through the senescence-associated secretory phenotype (SASP), including interferon-stimulated genes (ISGs). Here we confirm and extend previous observations that cyclin D1 (CCND1), a key cell cycle regulator, is paradoxically upregulated across models of nonproliferating senescent cells. We show that CCND1 and its kinase partner CDK6 drive SASP and ISG expression in senescent cells by promoting DNA damage accumulation. This leads to the formation of cytoplasmic chromatin fragments that activate pro-inflammatory cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling. In aged mouse livers, senescent hepatocytes show increased Ccnd1 expression. Hepatocyte-specific Ccnd1 knockout or treatment with the clinical grade CDK4/6 inhibitor palbociclib reduces DNA damage and ISGs in aged mouse liver. Further, palbociclib suppresses frailty and improves physical performance of aged mice. These findings demonstrate a role for CCND1/CDK6 in regulating DNA damage and inflammation in senescence and aging, highlighting it as a promising target for therapeutic repurposing.
- Open Access
- 24 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (30) , eadv9162
Single-cell analysis of the epigenome and 3D chromatin architecture in the human retina
Most genetic risk variants linked to ocular diseases are nonprotein coding and presumably contribute to disease through dysregulation of gene expression; however, understanding their mechanisms has been impeded by incomplete annotation of transcriptional regulatory elements across retinal cell types. To address this, we carried out single-cell multiomics assays to investigate gene expression, chromatin accessibility, DNA methylome, and three-dimensional (3D) chromatin architecture in human retina, macula, and retinal pigment epithelium/choroid. We identified 420,824 unique candidate regulatory elements and characterized their chromatin states in 23 retinal cell types. Comparative analysis of chromatin landscapes between human and mouse retina cells further revealed both evolutionarily conserved and divergent retinal gene-regulatory programs. Leveraging the advancements in deep-learning techniques, we developed sequence-based predictors to interpret noncoding risk variants of retinal diseases. Our study establishes retina-wide, single-cell transcriptome, epigenome, and 3D genome atlases and provides a resource for studying the gene regulatory programs of the human retina and ocular diseases.
- 24 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (30) , eadv9162
Open AccessSingle-cell analysis of the epigenome and 3D chromatin architecture in the human retina
Most genetic risk variants linked to ocular diseases are nonprotein coding and presumably contribute to disease through dysregulation of gene expression; however, understanding their mechanisms has been impeded by incomplete annotation of transcriptional regulatory elements across retinal cell types. To address this, we carried out single-cell multiomics assays to investigate gene expression, chromatin accessibility, DNA methylome, and three-dimensional (3D) chromatin architecture in human retina, macula, and retinal pigment epithelium/choroid. We identified 420,824 unique candidate regulatory elements and characterized their chromatin states in 23 retinal cell types. Comparative analysis of chromatin landscapes between human and mouse retina cells further revealed both evolutionarily conserved and divergent retinal gene-regulatory programs. Leveraging the advancements in deep-learning techniques, we developed sequence-based predictors to interpret noncoding risk variants of retinal diseases. Our study establishes retina-wide, single-cell transcriptome, epigenome, and 3D genome atlases and provides a resource for studying the gene regulatory programs of the human retina and ocular diseases.
- 23 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6809) , eady6893
Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure
Heart failure is a leading cause of morbidity and mortality, yet gene-regulatory mechanisms driving cell type–specific pathologic responses remain undefined. Here, we present the cell type–resolved transcriptomes, chromatin accessibility, histone modifications, and chromatin organization of 13 nonfailing and 23 failing human hearts across all cardiac chambers. Integrative analyses revealed dynamic changes in cell type composition, gene-regulatory programs, and chromatin organization, particularly in cardiomyocytes and fibroblasts. Mapping cell type–specific enhancer-gene interactions from these analyses enabled the illumination of likely causal genetic contributors to heart failure from genetic association data. Together, these findings provide multimodal gene-regulatory maps of the human heart in health and disease, offering a framework for designing precise, cell type–targeted therapies for treating heart failure.
- 23 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 393 (6809) , eady6893
Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure
Heart failure is a leading cause of morbidity and mortality, yet gene-regulatory mechanisms driving cell type–specific pathologic responses remain undefined. Here, we present the cell type–resolved transcriptomes, chromatin accessibility, histone modifications, and chromatin organization of 13 nonfailing and 23 failing human hearts across all cardiac chambers. Integrative analyses revealed dynamic changes in cell type composition, gene-regulatory programs, and chromatin organization, particularly in cardiomyocytes and fibroblasts. Mapping cell type–specific enhancer-gene interactions from these analyses enabled the illumination of likely causal genetic contributors to heart failure from genetic association data. Together, these findings provide multimodal gene-regulatory maps of the human heart in health and disease, offering a framework for designing precise, cell type–targeted therapies for treating heart failure.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
ATF3 target genes downregulated in K2 that harbor FOXA1 peaks in RT4
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
ATF3 target genes downregulated in K2 that harbor FOXA1 peaks in RT4